MARKETS
Markets

TScan Therapeutics Says It Received Nasdaq Notice Of Non-Compliance With $1.00 Minimum Bid Price Rule; Has Until February 23, 2027 To Regain Compliance

Sep 2, 2026 · 07:26 AM ET· updated 52m ago

Share
Why It Matters

TScan's stock price fell below $1.00, so Nasdaq (a big stock market) gave them until early 2027 to get it back up, or they could be removed from trading there. Watch whether the company can turn things around and get its stock price healthier again.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.